Prevalence of Telogen Effluvium in Egyptian Women with Post-Covid 19 Viral Infection
Abdo, H., Kadah, A., Saqaan, H. (2644). Prevalence of Telogen Effluvium in Egyptian Women with Post-Covid 19 Viral Infection. EKB Journal Management System, 2023(1), -. doi: 10.58675/2682-339X.1744
Hamed Mohamed Abdo; Ahmed Mohammed Said Kadah; Hamza Mohamad Saqaan. "Prevalence of Telogen Effluvium in Egyptian Women with Post-Covid 19 Viral Infection". EKB Journal Management System, 2023, 1, 2644, -. doi: 10.58675/2682-339X.1744
Abdo, H., Kadah, A., Saqaan, H. (2644). 'Prevalence of Telogen Effluvium in Egyptian Women with Post-Covid 19 Viral Infection', EKB Journal Management System, 2023(1), pp. -. doi: 10.58675/2682-339X.1744
Abdo, H., Kadah, A., Saqaan, H. Prevalence of Telogen Effluvium in Egyptian Women with Post-Covid 19 Viral Infection. EKB Journal Management System, 2644; 2023(1): -. doi: 10.58675/2682-339X.1744

Prevalence of Telogen Effluvium in Egyptian Women with Post-Covid 19 Viral Infection

Al-Azhar International Medical Journal
Volume 2023, Issue 1, January 2023  XML
DOI: 10.58675/2682-339X.1744
View on SCiNiTO View on SCiNiTO
Authors
Hamed Mohamed Abdo1; Ahmed Mohammed Said Kadah2; Hamza Mohamad Saqaan3
1Dermatology, Venereology and Andrology department, Faculty of Medicine, Al-Azhar University, Egypt
2Dermatology, Venereology and Andrology department, Al Hussein Hospital- Al-Azhar University, Egypt
3Dnipropetrovsk State Medical Academy -Ukraine
Abstract
Background: COVID-19 is a worldwide pandemic of concern. Frequent symptoms include fever and respiratory problems. Recent investigations have also identified dermatological manifestations as extrapulmonary symptoms. This includes telogen effluvium, which is associated with post-COVID-19 comorbidities. Aim and objectives: to draw attention to the common occurrence of telogen effluvium in Egyptian women who have viral infections after COVID 19. Subjects and methods: 500 female patients with COVID-19 virus infections from a few weeks to months prior were the subject of this investigation. The following procedures were applied to all patients: full general examination, complete history taking, clinical scalp and hair examination, including the hair pull test and part width test, and trichoscopic inspection. Result: Hospitalized for COVID19 and telogen effluvium differed statistically significantly (P = 0.001). Conclusion: Lower hair density, empty hair follicles, and/or short regrowing hair were early symptoms of after-COVID-19-caused acute TE. The results do not establish that COVID-19 is the only cause of acute TE; nevertheless, they do highlight the need to consider the COVID-19 pandemic when assessing patients who present with hair loss and a history of COVID-19 infection. Although acute TE doesn't often last long, it can have a significant influence on a person's mental health if they've previously been incapacitated by the COVID-19 sickness.
Keywords
COVID-19; Hair lose; Telogen Effluvium
Statistics
Article View: 20